Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2

Kamaleldin E Elagib1, Mang Xiao, Isa M Hussaini

  • 1University of Virginia School of Medicine, P.O. Box 800904, Charlottesville, VA 22908, USA.

Insights

Jun factors, like c-Jun, block red blood cell development by repressing GATA-1. A newly identified gene, HERP2, mediates this effect, revealing a novel pathway crucial for cell differentiation and potentially cancer.

Area of Science:

  • Molecular Biology
  • Cellular Differentiation
  • Oncogenesis

Background:

  • Jun factors, including c-Jun, are implicated in cancer development.
  • The downstream pathways regulated by Jun factors are not fully understood.
  • GATA-1 is a key regulator of red blood cell (erythroid) differentiation.

Purpose of the Study:

  • To elucidate the downstream pathways affected by Jun factors in oncogenesis.
  • To identify novel genes and mechanisms through which Jun factors regulate cellular differentiation.
  • To establish the link between Jun factors, HERP2, and GATA-1 in erythroid differentiation.

Main Methods:

  • Utilized primary human hematopoietic progenitors to study erythroid differentiation.
  • Employed mutagenesis of c-Jun to investigate its mechanism of repression.
  • Identified and characterized the hairy-enhancer-of-split-related factor HERP2.
  • Performed co-immunoprecipitation to assess physical interaction between HERP2 and GATA-1.
  • Transduced HERP2 into hematopoietic progenitors to assess its functional impact.

Main Results:

  • c-Jun inhibits erythroid differentiation in hematopoietic progenitors.
  • Jun factors repress the transcriptional activity of GATA-1.
  • HERP2 is a novel gene upregulated by c-Jun.
  • HERP2 physically interacts with GATA-1 and represses its transcriptional activity.
  • Expression of HERP2 inhibits erythroid differentiation.

Conclusions:

  • A novel regulatory pathway involving c-Jun, HERP2, and GATA-1 is defined.
  • This pathway links Jun factors to the inhibition of erythroid differentiation.
  • Establishes a connection between Notch signaling (via HERP factors) and GATA factors in differentiation.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...